Effects of cirrhosis on kinetics of aztreonam.

Aztreonam was administered as a single, 3-min, 1-g intravenous infusion to 18 subjects, including 6 with biopsy-proven, primary biliary cirrhosis, 6 with biopsy-proven, stable alcoholic cirrhosis, and 6 age- and sex-matched control subjects with normal hepatic functions. Aztreonam was well tolerated...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	MacLeod, C M, Bartley, E A, Payne, J A, Hudes, E, Vernam, K, Devlin, R G
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1984
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC179951/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6542764/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.26.4.493
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!